Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases
Visit us on the Web
Researchers Identify Genetic Marker of Artemisinin Resistance
NIAID researchers and their international colleagues have discovered a way to genetically identify Plasmodium falciparumparasites that are resistant to artemisinin, the key drug for treating malaria. In recent years, artemisinin-resistant malaria has appeared in patients in Southeast Asia, and being able to identify drug-resistant parasites would allow scientists to monitor the geographical spread of resistance.
To learn more about the study’s methods and findings, which appeared in this week’s Nature, see the NIAID media availability at: http://www.niaid.nih.gov/news/